Simon Brack
Head of Strategic Analysis, External Scientific Innovation Johnson & Johnson
Simon Brack is Head of Strategic Analysis, DPDS at Janssen Pharmaceutical Companies of Johnson & Johnson, where he focuses on strategic analysis within the Discovery, Product Development and Supply organization. Previously, he headed Oncology Discovery at Covagen/Janssen R&D in Zürich, leading multispecific antibody programs for immuno-oncology and contributing to the development of Covagen’s FynomAb pipeline. Simon joined Covagen in 2007, prior to its acquisition by Janssen in 2014. He holds a PhD from ETH Zürich, where he conducted his research in Professor Dario Neri’s laboratory.
Seminars
Tuesday 9th February 2027
Industry Leader’s Fireside Chat: Aligning the Future of In Vivo & Ex Vivo Cell Therapies for Greater Clinical & Commercial Impact
8:45 am
- Reviewing how emerging clinical data is shaping market perspectives on in vivo cell therapies to guide smart pipeline decisions
- Examining the resurgence of next-generation in vivo CAR-Ts and ex vivo explorations for solid tumours and autoimmune disease to identify where each modality can unlock the greatest opportunity
- Aligning scientific, manufacturing, regulatory and commercial perspectives on the future direction of the field to accelerate clinical impact
